August 5, 2022
Are you among the hundreds of millions of people worldwide with low back pain? If so, you may be familiar with standard treatments like surgery, shots, […]
August 5, 2022
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Emerging evidence is shedding light on the common underlying mechanisms contributing to […]
August 5, 2022
A variety of treatments, most already commercially available, are under investigation for treating the constellation of overlapping symptoms associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), “long […]
August 5, 2022
A rheumatologist was suspended from a professional society and his license to practice medicine was threatened after he raised concerns about data manipulation in a published […]
August 2, 2022
The US Food and Drug Administration has approved the dual interleukin (IL)-12 and IL-23 inhibitor ustekinumab (Stelara) for the treatment of juvenile psoriatic arthritis (jPsA) in […]
July 29, 2022
Upadacitinib (Rinvoq) has been approved by the European Commission for the treatment of active nonradiographic axial spondyloarthritis (nr-axSpA) in adults whose response to NSAIDS is inadequate, […]
July 28, 2022
The US Food and Drug Administration (FDA) has approved belimumab (Benlysta) for treating active lupus nephritis (LN) in children aged 5–17 years. The drug can now […]
July 28, 2022
Women with well-controlled rheumatoid arthritis (RA) who used a tumor necrosis factor (TNF) inhibitor during pregnancy gave birth to infants with higher birth weight than did […]
July 27, 2022
Taking vitamin D supplements did not significantly reduce the risk of fractures among adults in midlife and older adults, compared with placebo, according to results from […]